Shu‐Hui Lin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Viral-associated cancers and disorders
- Colorectal Cancer Surgical Treatments
- Peptidase Inhibition and Analysis
Papers in
-
- Cancer-related gene regulation 11
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 5
- Wnt/β-catenin signaling in development and cancer 5
- Oncology 20
- Peptidase Inhibition and Analysis 7
- Co-authors
- Kun‐Tu Yeh (24 shared papers)Shun‐Fa Yang (13 shared papers)Mu‐Kuan Chen (10 shared papers)Chiao‐Wen Lin (7 shared papers)Ming‐Ju Hsieh (8 shared papers)Yu‐Sheng Lo (8 shared papers)Shih‐Sung Chuang (9 shared papers)Yi‐Ching Chuang (7 shared papers)
- Journals
- Scientific Reports (4 papers)PLoS ONE (4 papers)Tumor Biology (3 papers)International Journal of Medical Sciences (2 papers)Environmental Toxicology (2 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Shu‐Hui Lin
81 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 238
- Oncology 363
- Pathology and Forensic Medicine 197
- Molecular Biology 548
- Periodontics 36
Countries citing papers authored by Shu‐Hui Lin
This map shows the geographic impact of Shu‐Hui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Hui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Hui Lin more than expected).
Fields of papers citing papers by Shu‐Hui Lin
This network shows the impact of papers produced by Shu‐Hui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Hui Lin. The network helps show where Shu‐Hui Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu‐Hui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 84 | |
| 2 | 2016 | 52 | |
| 3 | 2009 | 52 | |
| 4 | 2016 | 41 | |
| 5 | 2017 | 38 | |
| 6 | 2012 | 35 | |
| 7 | 2015 | 35 | |
| 8 | 2007 | 35 | |
| 9 | 2017 | 34 | |
| 10 | 2016 | 33 | |
| 11 | 2018 | 32 | |
| 12 | 2018 | 31 | |
| 13 | 2017 | 29 | |
| 14 | 2013 | 28 | |
| 15 | 2007 | 28 | |
| 16 | 2009 | 28 | |
| 17 | 2014 | 28 | |
| 18 | 2013 | 25 | |
| 19 | 2011 | 25 | |
| 20 | 2018 | 25 |
About Shu‐Hui Lin
Shu‐Hui Lin is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 87 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related gene regulation (11 papers), RNA modifications and cancer (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Peptidase Inhibition and Analysis (7 papers), Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Head and Neck Cancer Studies (4 papers). The work is most often cited by research in Cancer Research (238 citations), Oncology (363 citations), Pathology and Forensic Medicine (197 citations), Molecular Biology (548 citations) and Periodontics (36 citations). Shu‐Hui Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Kun‐Tu Yeh, Shun‐Fa Yang, Mu‐Kuan Chen, Chiao‐Wen Lin, Ming‐Ju Hsieh, Yu‐Sheng Lo, Shih‐Sung Chuang, Yi‐Ching Chuang, Sheng‐Tsung Chang and Chih‐Jung Chen. Their work appears in journals such as Scientific Reports, PLoS ONE, Tumor Biology, International Journal of Medical Sciences and Environmental Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.